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Abstract
Background: The magnitude of chronic infection with hepatitis B virus (HBV) varies substantially between the
countries. A better understanding of incidence and/ or prevalence of HBV infection and associated risk factors
provides insight into the transmission of this infection in the community. The purpose of this investigation was to
estimate the prevalence of and to identify the risk factors associated with chronic infection with HBV, as assessed
by HBV surface antigen (HBsAg) positivity, in asymptomatic volunteer male blood donors in Karachi, Pakistan.
Methods: Consecutive blood donations made at the two large blood banks between January 1, 1998 and
December 31, 2002 were assessed to estimate the prevalence of HBsAg positivity. To evaluate the potential risk
factors, a case-control study design was implemented; cases (HBsAg positives) and controls (HBsAg negatives),
were recruited between October 15, 2001 and March 15, 2002. A pre-tested structured questionnaire was
administered through trained interviewers to collect the data on hypothesized risk factors for HBV infection. Sera
were tested for HBsAg using commercially available kits for enzyme linked Immunosorbant assay-III.
Results: HBsAg prevalence in the male volunteer blood donors was 2.0 % (7048/351309). Multivariate logistic
regression analysis showed that after adjusting for age and ethnicity, cases were significantly more likely than
controls to have received dental treatment from un-qualified dental care provider (adjusted odds ratio (OR) =
9.8; 95% confidence interval (CI): 2.1, 46.1), have received 1–5 injections (adjusted OR = 3.3; 95% CI: 1.1, 9.6),
more than 5 injections (adjusted OR = 1.4; 95% CI: 1.4, 12.7) during the last five years or have received injection
through a glass syringe (adjusted OR = 9.4; 95% CI: 2.6, 34.3). Injury resulted in bleeding during shaving from
barbers (adjusted OR = 2.3; 95% CI: 1.1, 4.8) was also significant predictor of HBsAg positivity.
Conclusion: Prevalence of HBsAg positivity in the male volunteer blood donors in Karachi was 2%. Infection
control measures in health-care settings including safe injection practices and proper sterilization techniques of
medical instruments and education of barbers about the significance of sterilization of their instruments may
reduce the burden of HBV infection in this and similar settings. There is also an urgent need of developing locally
relevant guidelines for counseling and management of HBsAg positive blood donors.
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Background
In the absence of effective screening programs, hepatitis B
virus (HBV) is responsible for a substantial proportion of
cases of post-transfusion hepatitis, liver cirrhosis and
hepatocellular carcinoma [1]. An estimated 2 billion peo-
ple are infected with HBV worldwide, among them 350
millions are chronic carriers: hepatitis B surface antigen
(HBsAg) positive [2]. HBsAg positivity in developed coun-
tries varies from 0.6 percent in Wales, England, to 1.2 per-
cent in Texas, USA. However, higher prevalences of
infection with HBV have been reported from various parts
of the developing world including 3.5% in Gaza, Palestine
[3], 1.6%–7.7 % in Brazil [4,5], 19.6 % in Egypt [6], and
2%–10 % from various parts of India [7].
Intravenous drug use, needle stick injuries, haemodialysis,
tattooing and multiple sexual partners have been identi-
fied as common modes of HBV transmission in the devel-
oped world [8]. In many developing countries however,
the relative contributions of various routes of HBV infec-
tion have not been defined in population-based studies.
Due to a lack of universal and appropriate blood screen-
ing in these countries, the risk of post-transfusion HBV
infection is still unknown. Parenteral routes implicated as
the most likely factors for HBV transmission include un-
sterilized needles and syringes in health-care settings [9-
11], Moreover, in low socio-economic settings, horizontal
transmissions of HBV through contact with infected fam-
ily member have also been reported [12], but these find-
ings are yet to be verified.
The national estimates for prevalence and/or incidence of
HBV infection in Pakistan are unknown. However, studies
in selected groups have shown variable prevalence of
chronic infection with HBV as assessed by HBsAg positiv-
ity: 7% in health professionals [13], 2%–14% in blood
donors [14-17]. Pre-employment screening revealed 2.6%
HBsAg positivity among the healthy individuals in north-
ern Pakistan [18]. Moreover, some hospital-based studies
have revealed that 30% – 42% of the cases of chronic liver
disease [19,20] and 78% of the cases of hepatocellular car-
cinoma [19] were positive for HBsAg.
Developed countries have been successful in reducing the
risk of HBV spread by interrupting some of the known
routes of HBV transmission and through mass HBV vacci-
nations. The vaccine against HBV infection is available in
most of the developing world including Pakistan, but its
high cost limits the widespread use. Recently, Pakistan ini-
tiated universal HBV vaccination for neonates through its
expanded program of immunization with the assistance
of Global Alliance for Vaccines and Immunization [2].
However, public health benefits of this initiative require
some time to accrue as the program focuses on neonates
only [10]. Therefore, a multi-prong approach needs to be
undertaken to curtail the spread of HBV infection in Paki-
stan and perhaps other developing countries in the
region.
Volunteer blood donors are generally regarded as a
healthier segment of any community, as blood banks usu-
ally have strict selection criteria that helps identify, and
consequently bleed healthy donors only [21]. The propor-
tion of HBsAg positive donors and risk factor(s) associ-
ated with HBsAg positive status among these healthy
individuals may reflect the magnitude of chronic HBV
infection in the general population. Therefore, we con-
ducted this study to estimate the prevalence of and to
identify the risk factors associated with HBsAg positivity
in asymptomatic male volunteer blood donors in Karachi.
Methods
Study design and setting
The study design, setting and data collection procedures
have been described elsewhere [22], and we briefly out-
lined here. This study was conducted at two large blood
banks (I and II) in Karachi. Blood bank I is located in a ter-
tiary care teaching hospital in private sector and caters for
the need of inpatients. Blood bank II belongs to a non-
government organization (NGO) and caters the need of
all those who need blood transfusion including patients
of leukaemia, haemophilia, thalassaemia and other blood
related diseases. Both the blood banks receive blood
donations as replacements from volunteers and admit for
screening apparently healthy individuals. Preliminary
screening includes a personal interview with the donor
and exclusion of those who admit to known risk factors
for hepatitis B and C and human immunodeficiency virus
infections.
HBsAg test results of consecutive blood donations made
between January 1, 1998 and December 31, 2002 at blood
bank I, and from January 1, 1999 to December 31, 2002
at blood bank II were available to assess the proportions
of HBsAg positive donors. To evaluate the potential risk
factors for HBsAg positivity, a case-control study design
was implemented.
Recruitment of cases and controls
Between October 15, 2001 and March 15, 2002, eligible
blood donors aged 18–64 years, and HBsAg positive were
defined as cases and those who were HBsAg negative were
taken as controls. Study subjects were contacted after
obtaining their addresses and phone numbers from
records of respective blood banks. After explaining the
objectives and potential risks/benefits of the study, sub-
jects were invited to participate in the study.BMC Gastroenterology 2005, 5:26 http://www.biomedcentral.com/1471-230X/5/26
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Data collection and serology
A pre-tested structured questionnaire was used to collect
data from both cases and controls regarding demographic,
and socioeconomic attributes, various potential
parenteral exposures to blood or blood products and non-
parentral modes of HBV transmission. Both the blood
banks use commercially available enzyme-linked immu-
nosorbant assay-III (ELISA) kits to detect HBsAg as a
marker for chronic HBV infection. ELISA results are inter-
preted essentially following the instructions of the manu-
facturer. This study complied with the human subjects'
protection requirement of the institutional ethics
committee.
Data analysis
Data were managed and analyzed using Epi-Info (version
6.04: Centres for Disease Control and Prevention, Atlanta,
GA, USA) and SPSS (version 10.0: SPSS Inc., Chicago, IL,
USA) respectively. Overall HBsAg prevalence and HBsAg
prevalence by year and by blood bank was computed.
Chi-square analysis for trend was carried out to assess the
significance of the change in proportions of HBsAg posi-
tive donors over the entire study period. Descriptive statis-
tics were computed for demographic variables for both
cases and controls. To asses univariate associations
between HBsAg positivity and hypothesized risk factors,
odds ratios (ORs) and their corresponding 95% confi-
dence intervals (CIs) were calculated using simple logistic
regression analysis. A final set of independent risk factors
for HBsAg positivity among the donors was derived by a
backward stepwise logistic regression model. The risk fac-
tors significantly (P = 0.2) related with outcome on uni-
variate analyses were considered for inclusion in the final
model. After arriving at main effects model, plausible
interaction terms were also evaluated for inclusion in the
model. The adjusted ORs and their 95% CIs were
obtained from final model and used for substantive inter-
pretation of the model. The fit of the final model was
assessed by the Hosmer-Lemeshow's goodness-of-fit test
[23].
Results
HBsAg prevalence
The overall HBsAg prevalence in this study was 2.0%
(7048/351309). HBsAg positivity among the donors at
blood bank I was 1.0 % (782/75752), whereas, corre-
sponding figure for the donors at blood bank II was 2.3%
(6266/275557). Blood donations and proportions of
HBsAg positive donors by blood bank and by year are
given in Table 1. The proportions of HBsAg positive
donors were consistently higher at blood bank II than
blood bank I across the study period. Trend analysis
revealed an overall significant (P < 0.001) increase in the
proportions of HBsAg positive donors from 1998 to 2002
for combined data and for the data from blood bank I.
However, for blood bank II there was significant (P <
0.001) downward trend in the proportions of HBsAg pos-
itive donors.
Characteristics of cases and controls
In this study 64 cases and 260 controls were enrolled.
About 81% of cases and 86% of controls were 35 years of
age or less. Forty seven percent of cases and 61% of con-
trols belonged to Mohajir ethnicity, almost representing
the composition of general population of Karachi. Fifty
three percent of cases and 61% of controls had 10 or more
years of schooling and 45% of cases were ever-married
compared to 56% of controls. The distributions of profes-
sion, household income, number of blood donations in
the past, parenteral and non-parenteral factors considered
are given in Table 2.
Risk factor analysis
On univariate analyses, death of a family member due to
liver disease, dental treatment received from a un-quali-
fied provider, therapeutic injections received in the past,
Table 1: Total blood donations and proportions of hepatitis B virus (HBV) infected donors at two large blood banks in Karachi, 1998–
2002
Blood bank 1 Blood bank 2 Blood banks combined
Year Total HBV+ (%)a Total HBV+ (%)b Total HBV+ (%)c
1998** 15068 117 (0.8) -- -- 15068 117 (0.8)
1999 14856 72 (0.5) 62566 1530 (2.4) 77422 1602 (2.1)
2000 15525 95 (0.6) 66486 1566 (2.4) 82011 1661 (2.0)
2001 15084 230 (1.5) 74154 1654 (2.2) 89238 1884 (2.1)
2002 15219 268 (1.8) 72351 1516 (2.1) 87570 1784 (2.0)
Total 75752 782 (1.0) 75557 6266 (2.3) 351309 7048 (2.0)
**Data for 1998 were not available for blood bank 2;aχ2
trend = 170.81 (P < 0.001); bχ2
trend = 21.28 (P < 0.001); cχ2
trend = 123.05 (P < 0.001)BMC Gastroenterology 2005, 5:26 http://www.biomedcentral.com/1471-230X/5/26
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Table 2: Univariate analysis of putative risk factors for hepatitis B virus infection in a case-control study of volunteer blood donors 
from two large blood banks, Karachi, Pakistan
Variables Cases Controls OR† 95% CI‡
n = 64 % n = 260 %
Blood bank
Blood bank 1 38 (59.4) 118 (45.4) 1.0 -
Blood bank II 26 (40.6) 142 (54.6) 0.6 0.3–1.0
Age (completed years)
15–25 23 (35.9) 139 (53.5) 1.0 -
26–35 29 (45.3) 86 (33.1) 2.0 1.1–3.8
> 36 12 (18.8) 35 (13.5) 2.1 0.9–5.6
Ethnicity
Mohajir 30 (46.9) 158 (60.8) 1.0 -
Punjabi 8 (12.5) 45 (17.3) 0.9 0.4–2.2
Pathan 11 (17.2) 17 (6.5) 3.4 1.5–8.0
Sindhi 5 (7.8) 15 (5.8) 1.8 0.6–5.2
Baloch and others 10 (15.6) 25 (9.6) 2.1 0.9–4.8
Education (completed school years)
>10 34 (53.1) 159 (61.2) 1.0 -
≤ 10 30 (46.9) 101 (38.8) 1.4 0.8–2.5
Marital status
Never married 29 (45.3) 146 (56.2) 1.0 -
Ever married 35 (54.7) 114 (43.8) 1.5 0.9–2.7
Profession
Un-employed 8 (12.5) 50 (19.2) 1.0 -
Self-employed 19 (29.7) 39 (15.0) 3.0 1.1 – 8.6
Service provider 37 (57.8) 171 (65.8) 1.4 0.6 – 3.4
*Household income (Pak Rs./mo)
> 15000 11 (18.3) 33 (15.3) 1.0 -
8001–15000 16 (26.7) 71 (33.0) 0.7 0.3 – 1.8
5001–8000 9 (15.0) 50 (23.3) 0.5 0.2 – 1.6
≤ 5000 24 (40.0) 61 (28.4) 1.2 0.5 – 2.9
Number of times donated blood
1 21 (32.8) 93 (35.8) 1.0 -
2 13 (20.3) 52 (20.0) 1.1 0.5–2.6
>2 30 (46.9) 115 (44.2) 1.2 0.6–2.3
History of hospital admission
0 50 (78.1) 196 (75.4) 1.0 -
1 13 (20.3) 53 (20.4) 0.9 0.5–2.0
>1 1 (1.6) 11 (4.2) 0.4 0.1–2.8
History of dental treatment
Never had dental treatment 31 (48.4) 183 (70.4) 1.0 -
Treated by dentist 24 (24.0) 73 (28.1) 1.9 1.1–3.5
Treated by others 9 (9.0) 4 (1.5) 13.2 3.9–45.8
Last injection received (completed months)
Never received injection 5 (7.8) 63 (24.2) 1.0 -
≥ 6 34 (53.1) 123 (47.3) 3.5 1.3–9.3
< 6 25 (39.1) 74 (28.5) 4.3 1.5–11.8BMC Gastroenterology 2005, 5:26 http://www.biomedcentral.com/1471-230X/5/26
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Injections received in last one year
0 27 (42.2) 167 (64.2) 1.0 -
1 8 (12.5) 19 (7.3) 2.6 1.0–6.5
2 – 5 19 (29.7) 49 (18.8) 2.4 1.2–4.7
≥ 6 10 (15.6) 25 (9.6) 2.5 1.1–5.7
Injections received in five years
0 15 (23.4) 119 (45.8) 1.0 -
1–5 23 (35.9) 84 (32.3) 2.2 1.1–4.4
> 5 26 (40.6) 57 (21.9) 3.6 1.8–7.4
Injections received in ten years
0 40 (62.5) 167 (64.2) 1.0 -
1–10 16 (16.0) 75 (28.8) 0.9 0.5–1.7
>10 8 (8.0) 18 (6.9) 1.9 0.7–4.6
Type of syringe used for the last injection
Never had injection 8 (12.5) 92 (35.4) 1.0 -
Plastic syringe 31 (48.4) 131 (50.4) 2.7 1.1–6.2
Glass syringe 25 (39.1) 37 (14.2) 7.8 3.2–18.8
IV infusion received from
Never had drip 36 (56.3) 156 (60.0) 1.0 -
Hospital 6 (9.4) 49 (18.8) 0.5 0.2–1.3
GP's and others 22 (34.4) 55 (21.2) 1.7 0.9–3.2
IV infusion received in last one year
0 53 (82.8) 240 (92.3) 1.0 -
1 5 (7.8) 16 (6.2) 1.4 0.5–4.0
≥ 2 6 (9.4) 4 (1.5) 6.8 1.9–25.0
IV infusion received in last five years
0 47 (73.4) 202 (77.7) 1.0 -
1–4 12 (18.8) 54 (20.8) 1.0 0.5–1.9
≥ 5 5 (7.8) 4 (1.5) 5.3 1.4–20.8
IV infusions received in last ten years
0 42 (65.6) 171 (65.8) 1.0 -
1–4 15 (23.4) 79 (30.4) 0.8 0.5–1.5
≥ 5 7 (10.9) 10 (3.8) 2.9 1.0–8.0
Ear pierced
No 62 (96.9) 248 (95.4) 1.0 -
Yes 2 (3.1) 12 (4.6) 0.7 0.2–3.1
Tattooing
No 61 (95.3) 249 (95.8) 1.0 -
Yes 3 (4.7) 11 (4.2) 1.1 0.3–4.1
Shaving from barber
No 17 (26.6) 100 (38.5) 1.0 -
Yes 47 (73.4) 160 (61.5) 1.7 0.9–3.2
Frequency of going to barber
Never 17 (26.6) 100 (38.5) 1.0 -
Daily 17 (26.6) 65 (25.0) 1.5 0.7–3.2
Once a week 19 (29.7) 59 (22.7) 1.9 0.9–3.9
More than once a week 11 (17.2) 36 (13.8) 1.8 0.8–4.2
Table 2: Univariate analysis of putative risk factors for hepatitis B virus infection in a case-control study of volunteer blood donors 
from two large blood banks, Karachi, Pakistan (Continued)BMC Gastroenterology 2005, 5:26 http://www.biomedcentral.com/1471-230X/5/26
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type of syringe used for therapeutic injections, intrave-
nous infusions received in the past, bleeding during shav-
ing from barbers and sexual intercourse with multiple
partners were significantly (P  ≤ 0.05) associated with
HBsAg positivity (Table 2).
Final multivariate logistic regression model revealed that
cases were significantly more likely than controls to have
received dental treatment from un-qualified provider
(adjusted OR = 9.8; 5% CI: 2.1, 46.1). Also, cases com-
pared to controls were significantly more likely to have
received 1–5 injections (adjusted OR = 3.3; 5% CI: 1.1,
9.6) or >5 injections (adjusted OR = 1.4; 5% CI: 1.4, 12.7)
during the last five years. Furthermore, cases were signifi-
cantly more likely to have been injected medicine with a
glass syringe by health-care providers (adjusted OR = 9.4;
5% CI: 2.6, 34.3). Bleeding during shaving from barbers
was independently and significantly associated with
HBsAg positivity (adjusted OR = 2.3; 5% CI: 1.1, 4.8) in
this study. The Hosmer-Lemeshow goodness-of-fit test
statistic showed a good fit for the final model (χ2 = 7.82,
P = 0.349) (Table 3).
Death of a family member due to liver disease
No 55 (85.9) 24.8 (95.4) 1.0 -
Yes 9 (14.1) 12 (4.6) 3.4 1.4–8.4
Lived with jaundiced family member
No 38 (59.4) 190 (73.1) 1.0 -
Yes 26 (40.6) 70 (26.9) 1.9 1.0–3.4
History of sexual contact
No history of sexual contact 24 (37.5) 130 (50.0) 1.0 -
Sexual contact with ≥ 1 partners 40 (62.5) 130 (50.0) 1.6 0.9–3.0
• Commercial Sex worker †Odds ratio ‡Confidence Interval
•χ Who provides services like laborer, driver, policeman, factory worker etc.
Table 3: Multivariate logistic regression model of risk factors associated with hepatitis B virus infection in asymptomatic volunteer 
blood donors in a case-control study, Karachi, Pakistan.
Adjusted odds ratio 95 % confidence interval
History of dental treatment
Never had dental treatment 1.0 -
Treated by dentist 1.6 0.7 – 3.6
Treated by un-qualified provider 9.8 2.1 – 46.1
Number of therapeutic injection received in last five 
years
0 1.0 -
1–5 3.3 1.1 – 9.6
> 5 4.2 1.4 – 12.7
Type of syringe used for the last injection
Never had injection 1.0 -
Plastic 1.8 0.5 – 6.4
Glass 9.4 2.6 – 34.3
Injury resulted in bleeding during facial shaving 
from barber
No 1.0 -
Yes 2.3 1.1 – 4.8
Table 2: Univariate analysis of putative risk factors for hepatitis B virus infection in a case-control study of volunteer blood donors 
from two large blood banks, Karachi, Pakistan (Continued)BMC Gastroenterology 2005, 5:26 http://www.biomedcentral.com/1471-230X/5/26
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Discussion
The objectives of this study were to estimate the preva-
lence of and to identify the risk factors for chronic infec-
tion with HBV as assessed by the HBsAg positivity through
ELISA-III among volunteer blood donors in Karachi. An
overall 2% HBsAg prevalence among volunteer blood
donors in this study was recorded, which is lower than the
figures reported from some other high HBV prevalence
developing countries including 3.4% in Georgia [24],
4.5% in Taiwan [25], and 5.8% in Indonesia [26]. With
HBsAg prevalence of 2%, Pakistan falls into intermediate
range of HBV infection suggesting a need for screening of
pregnant women at minimum and universal childhood
vaccination against HBV. However, a much lower preva-
lence of infection with HBV has been reported from some
developed countries, for instance 0.8% in Australia [27]
and 1.1% in Denmark [28], which reflect the efficacy of
blood donor selection policies, effective screening pro-
grams and very low HBV prevalence in general population
in these countries. Similar strategies may play a significant
role in reducing post-transfusion HBV infection in
Pakistan.
The proportions of HBsAg positive blood donors were
consistently higher at blood bank II (2.3%) than at blood
bank I (1.0%) across the study period. As mentioned ear-
lier that blood bank I receives blood donations from the
relatives/friends of the hospital in-patients only, and
usually patients from middle and higher socioeconomic
class utilize the services of this hospital. Being a subsidiary
of an NGO, blood bank II caters the need of all patients
requiring blood transfusion in the city including patients
from public funded hospitals, which are generally
attended by the lower or middle class patients. It has been
well documented that HBV infection is more prevalent in
low socioeconomic settings in Indonesia [29], or perhaps
similar setting in Pakistan. Therefore, the difference in the
HBsAg positivity may be attributed to the apparent differ-
ence in populations attending these two blood banks.
Although trend analysis revealed significant changes over
time (1998–2002) in proportions of donors positive for
HBsAg at blood bank I, blood bank II and for combined
data but these changes do not seem to be substantial.
Therefore, given the large sample size and the observa-
tional design of the study, this statistically significant
change in the proportions over time may be discounted.
Nonetheless, further study is indicated to discern this pat-
tern using detailed time series data.
We found that subjects with a history of dental treatment
received from unqualified provider had an increased risk
for HBsAg positivity; consistent with previous research
[30]. Dental practice by unregistered practitioners is
common in developing countries. These non-medical per-
sonals, besides their technical incompetence, do not prop-
erly sterilize their equipments and thereby transmit blood
borne infections to their patients. Strict enforcement of
legislation to ban such illegal practices may result in sub-
stantial reduction in HBV transmission in this and similar
settings.
Therapeutic injections received during the past five years
were significantly associated with HBsAg status in this
study. HBV transmission through contaminated needles is
well established [31]. In Pakistan, the proportion of injec-
tions per prescription is one of the highest compared to
some other countries [32-34]. In developing countries, a
large proportion of patients preferred injected medicines
and considered them more efficacious than other routes
of drug administration [32,34]. In addition to patient
preference for injections, physicians' prescribing practices,
their belief in better efficacy of injected drugs, direct
observation of the prescribed therapy, patients demand
and financial incentive have been reported as the reasons
for increased frequency of injections in developing coun-
tries [35]. Therefore, interventions to improve injection
safety and reduce injection overuse would have a substan-
tial impact on the incidence of infection with HBV.
This study showed a strong association between use of
glass syringe for therapeutic injection and HBsAg status.
The use of glass syringes in administering therapeutic
injections has been common in the past, and is still in
practice in most of the low socioeconomic settings in
developing countries. The 'boiling method' employed to
sterilize glass syringes in most of the health facilities is in-
adequate for complete sterilization. Therefore, these glass
syringes act as a source for transmitting HBV and other
blood borne pathogens [7,36-38]. Taking into account the
hazards of glass syringes, their use should be banned by
public health authorities in Pakistan and perhaps other
developing countries in the region.
Bleeding during facial shaving from barbers was signifi-
cantly associated with the outcome in this study. Facial
shaving from barbers has been repeatedly documented as
a risk factor for transmission of hepatitis B and C viruses
in various countries [39-41]. Barbers in this part of the
world are mostly un-aware of the transmission of blood
borne pathogens through shaving tools [41]. The repeated
use of potentially contaminated razors and other non-
sterilized shaving tools most likely infect their clients with
HBV and other blood-borne infections. Therefore, health
education programs focusing on barbers' community may
contribute to the reduction in HBV transmission in this
and other similar settings.
Some limitations of this study need to be considered in
interpreting the present findings. Volunteer blood donors
are a low-risk healthier segment of any community [42],BMC Gastroenterology 2005, 5:26 http://www.biomedcentral.com/1471-230X/5/26
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who are further screened for symptoms of various medical
conditions at the blood banks. Hence, we expect a consid-
erable 'healthy donor effect – relatively weaker associa-
tions of the risk factors with HBsAg positivity in this
population. Furthermore, subjects with long-standing
HBsAg positive status could be sicker with hepatocelluar
carcinoma or cirrhosis, perhaps too sick to come to
donate blood and resulting into underestimation of prev-
alence of HBsAg positivity. Recall bias – an inherent limi-
tation of a case-control design, might have been
introduced in measurement of some of the variables,
especially when past histories of injections and intrave-
nous infusions were explored [43]. However, to minimize
recall bias, we asked injection and infusion history of dif-
ferent eras: six months to ten years. Any bias that might
have occurred must be non-differential, thus yielded con-
servative estimates of observed relationships. For eco-
nomic reasons we were unable to test for some other
markers of active HBV infection such as HBV DNA and/or
hepatitis B e antigen (HBeAg), and IgM anti-HBc – an
indicator of early acute HBV infection,. Therefore, some
donors in this category may have been missed since some
patients with acute self-limited primary HBV infection
never have detectable HBsAg in the blood [44]. However,
considering the sample size in this study, we hope such
misclassification to be minimal. In the case-control arm of
the study, we did not test controls for anti-HBs (antibod-
ies to HBsAg) to exclude those who might have resolved
past infection, became immune and lacked potential to
become case as defined in this study. Ascertainment of
controls' serostatus may have non-differentially led to
controls who are not susceptible to HBV infection due to
previous infection or immunization, thereby biasing
results toward the null. Future studies should take this
aspect in to account. The proportion of female donors in
the selected blood banks was quite low; therefore,
excluded from the present analysis. Study in female blood
donors might show a different set of risk factors.
Conclusion
The prevalence of HBsAg positivity was 2% in male volun-
teer blood donors in this study. A history of dental treat-
ment received from un-qualified provider, the number of
therapeutic injection received during the past five years
and use of glass syringe for therapeutic injections, bleed-
ing during facial shaving from a barber were independent
risk factors for HBsAg positivity in this study population.
Therefore, educational intervention targeted on health-
care professionals about the importance of infection con-
trol measures may include safe injection practices and
proper sterilization of medical and dental instruments.
Education of barbers about the significance of
sterilization of their instruments may help in reducing the
burden of community-acquired infection with HBV and
other blood-borne pathogens in this and similar settings.
Strict enforcement of legislation to ban un-qualified den-
tal practitioners may further help curb the HBV spread.
There is also an urgent need to develop locally relevant
guidelines for further management of HBsAg positive
donors. A cohort study of donors preferably on those who
routinely volunteer should focus both on acute and well
as chronic HBV infection to seek better estimate of the
magnitude of the problem by incorporating relevant diag-
nostic tests.
Competing interests
The author(s) declare that they have no competing
interests.
Authors' contributions
SA conceived and designed the study. SA and MY designed
the study questionnaire. MY, SD, FH SHJ participated in
the implementation of the study. SA and MY were respon-
sible for data analysis and manuscript writing. All the
authors read and approved the manuscript.
Acknowledgements
We sincerely thank the study participants. We highly appreciate the coop-
eration and assistance we received from the administration and staff of the 
blood banks. We also gratefully acknowledge the help of Dr. Mohammad 
Mustafa Qureshi and Dr. Hafiz Irfan in the conduct of this study. We wish 
to thank the reviewers of the journal for their thoughtful comments, which 
helped in bringing about substantive clarity in this manuscript.
References
1. Torbenson M, Thomas DL: Occult hepatitis B.  Lancet Infec Dis
2002, 2:479-486.
2. World Health Organization: Hepatitis B.  Fact sheet 2000. WHO/
204
3. Yassin K, Awad R, Tebi AJ, Queder A, Laaser U: Prevalence and
risk factors of HBsAg in Gaza: implications for prevention
and control.  J Infect 2002, 44:252-256.
4. Arboleda M, Castilho MC, Fonseca JC, Albuquerque BC, Saboia RC,
Yoshida CF: Epidemiological aspects of hepatitis B and D virus
infection in thenorthern region of Amazonas, Brazil.  Trans
Roy Soc Trop Med Hyg 1995, 89:481-483.
5. Passos AD, Gomes UA, Figueiredo JF, do Nascimento MM, de
Oliveira JM, Gaspar AM, Yoshida CF: Influence of migration on
the prevalence of serologic hepatitis B markers in a rural
community. 1. Analysis of prevalence by birthplace.  Revista
De Saude Publica 1993, 27:30-35.
6. el-Sayed HF, Abaza SM, Mehanna S, Winch PJ: The prevalence of
hepatitis B and C infections among immigrants to a newly
reclaimed area endemic for Schistosoma mansoni in Sinai,
Egypt.  Acta Tropica 1997, 68:229-237.
7. Chowdhury A, Santra A, Chaudhuri S, Ghosh A, Banerjee P, Mazum-
der DN: Prevalence of hepatitis B infection in the general
population: a rural community based study.  Trop Gastroenterol
1999, 20:75-77.
8. Custer B, Sullivan SD, Hazlet TK, Iloeje U, Veenstra DL, Kowdley KV:
Global epidemiology of hepatitis B virus.  J Clin Gastroenterol
38(10 Suppl):S158-S168.
9. Aylward B, Lloyd J, Zaffran M, McNair-Scott R, Evans P: Reducing
the risk of unsafe injections in immunization programmes:
financial and operational implications of various injection
technologies.  Bull World Health Organ 1995, 73:531-540.
10. Usman HR, Akhtar S, Rahbar MH, Hamid S, Moattar T, Luby SP:
Injections in health care settings: a risk factor for acute hep-
atitis B virus infection in Karachi, Pakistan.  Epidemiol Infect
2003, 130:293-300.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Gastroenterology 2005, 5:26 http://www.biomedcentral.com/1471-230X/5/26
Page 9 of 9
(page number not for citation purposes)
11. Khan AJ, Luby SP, Fikree F, Karim A, Obaid S, Dellawala S, Mirza S,
Malik T, Fisher-Hoch S, McCormick JB: Unsafe injections and the
transmission of hepatitis B and C in a periurban community
in Pakistan.  Bull World Health Organ 2000, 78:956-963.
12. Doganci T, Uysal G, Kir T, Bakirtas A, Kuyucu N, Doganci L: Hori-
zontal transmission of hepatitis B virus in children with
chronic hepatitis B.  World J Gastroenterol 2005, 11:418-420.
13. Shaikh MH: Prevalence of HBV markers in health care person-
als and control.  J Coll Physicians Surg Pak 1995, 5:19-21.
14. Chaudhry NT, Khan SJ, Khan TA, Saeed M, Syed M, Iqbal J, Ahmed S,
Saleem M, Yaqub : Prevalence of hepatitis B carriers and blood
group frequency in voluntary blood donors.  J Ayub Med Coll
Abbottabad 1996, 8:29-32.
15. Rehman K, Khan AA, Haider Z, Shahzad A, Iqbal J, Khan RU, Ahmad
S, Siddiqui A, Syed SH: Prevalence of seromarkers of HBV and
HCV in health care personnel and apparently healthy blood
donors.  J Pak Med Assoc 1996, 46:152-154.
16. Kakepoto GN, Bhally HS, Khaliq G, Kayani N, Burney IA, Siddiqui T,
Khurshid M: Epidemiology of blood-borne viruses: a study of
healthy blood donors in Southern Pakistan.  Southeast Asian J
Trop Med Public Health 1996, 27:703-706.
17. Tareen S, Eslick GD, Kam EP, Byles JE, Durrani AB, Maree SM: High
prevalence of hepatitis B virus (HBV) among male blood
donors in a developing country: urgent need for systematic
screening.  Scand J Infect Dis 2002, 34:712-713.
18. Khokhar N, Gill ML, Malik GJ: General seroprevalence of hepa-
titis C and hepatitis B virus infections in population.  J Coll Phy-
sicians Surg Pak 2004, 14:534-536.
19. Tong CY, Khan R, Beeching NJ, Tariq WU, Hart CA, Ahmad N, Malik
IA: The occurance of hepatitis B virus and HCV in Pakistani
patients with chronic liver disease and hepatocellular
carcinoma.  Epidemiol Infect 1996, 117:327-332.
20. Khan TS, Rizvi FJ: Hepatitis B seropositivity among chronic
liver disease patients in Hazara division Pakistan.  J Ayub Med
Coll Abbottabad 2003, 15:54-55.
21. Pillonel J, Saura C, Courouce AM: Prevalence of HIV, HTLV, and
hepatitis B and C viruses in blood donors in France, 1992–
1996.  Transfus Clin Biol 1998, 5:305-312.
22. Akhtar S, Younus M, Adil S, Jafri SH, Hassan F: Hepatitis C virus
infection in asymptomatic male volunteer blood donors in
Karachi, Pakistan.  J Viral Hepat 2004, 11:527-535.
23. Hosmer DW Jr, Lemeshow S: Applied Logistic Regression.  New
York: John Wiley & Sons; 1989:307. 
24. Butsashvili M, Tsertsvadze T, McNutt LA, Kamkamidze G, Gvetadze
R, Badridze N: Prevalence of hepatitis B, hepatitis C, syphilis
and HIV in Georgian blood donors.  Eur J Epidemiol 2001,
17:693-695.
25. Tsai SJ, Chen CJ, Hsieh YS, Yang CS: Seroprevalence of anti-HCV
among voluntary blood donors in Taiwan.  Zhonghua Min Guo
Wei Sheng Wu Ji Mian Yi Xue Za Zhi 1991, 4:61-70.
26. Budihusodo U, Sulaiman HA, Akbar HN, Lesmana LA, Waspodo AS,
Noer HM, Akahane Y, Suzuki H: Seroepidemiology of HBV and
HCV infection in Jakarta, Indonesia.  Gastroenterol Jpn 1991,
26(Suppl 3):196-201.
27. Correll PK, Law MG, Seed CR, Gust A, Buring M, Dax EM, Keller AJ,
Kaldor JM: Variant Creutzfeldt-Jakob disease in Australian
blood donors: estimation of risk and the impact of deferral
strategies.  Vox Sang 2001, 81:6-11.
28. Christensen PB, Titlestad IL, Homburg KM, Georgsen J, Kristensen T:
Hepatitis B core antibodies in Danish blood donors: a surro-
gate marker of risk behaviour.  Vox Sang 2001, 81:222-227.
29. Akbar N, Basuki B, Mulyanto M, Garabrant DH, Sulaiman A, Noer
HM: Ethnicity, socioeconomic status, transfusions and risk of
hepatitis B and hepatitis C infection.  J Gastroenterol Hepatol
1997, 12:752-757.
30. Cisneros-Castolo M, Hernandez-Ruiz L, Ibarra-Robles IE, Fernandez-
Garate IH, La Pena JE: Prevalence of hepatitis B virus infection
and related risk factors in a rural community of Mexico.  Am
J Trop Med Hyg 2001, 65:759-763.
31. Kane A, Lloyd J, Zaffran M, Simonsen L, Kane M: Transmission of
hepatitis B, hepatitis C and human immunodeficiency
viruses through unsafe injections in the developing world:
model-based regional estimates.  Bull World Health Organ 1999,
77:801-807.
32. Simonsen L, Kane A, Lloyd J, Zaffran M, Kane M: Unsafe injections
in the developing world and transmission of blood-borne
pathogens: a review.  Bull World Health Organ 1999, 77:789-800.
33. Thaver IH: Prescribing patterns of primary care providers in
squatter areas of Karachi.  J Pak Med Assoc 1995, 45:301-302.
34. Janjua NZ, Akhtar S, Hutin YJF: Injection use in two districts of
Pakistan: implications for disease prevention.  Int J Qual Health
Care 2005 in press.
35. Reeler AV: Anthropological perspectives on injections: a
review.  Bull Wrld Hlth Org 2000, 78:135-143.
36. Ko YC, Li SC, Yen YY, Yeh SM, Hsieh CC: Horizontal transmis-
sion of hepatitis B virus from siblings and intramuscular
injection among preschool children in a familial cohort.  Am J
Epidemiol 1991, 133:1015-1023.
37. Singh J, Bhatia R, Gandhi JC, Kaswekar AP, Khare S, Patel SB, Oza VB,
Jain DC, Sokhey J: Outbreak of viral hepatitis B in a rural com-
munity in India linked to inadequately sterilized needles and
syringes.  Bull World Health Organ 1998, 76:93-98.
38. Voelker R: Eradication efforts need needle-free delivery.  JAMA
1999, 281:1879-1881.
39. Mele A, Corona R, Tosti ME, Palumbo F, Moiraghi A, Novaco F,
Galanti C, Bernacchia R, Ferraro P: Beauty treatments and risk of
parenterally transmitted hepatitis: results from the hepatitis
surveillance system in Italy.  Scand J Infect Dis 1995, 27:441-444.
40. Yee LJ, Weiss HL, Langner RG, Herrera J, Kaslow RA, Leeuwen DJV:
Risk factors for acquisition of hepatitis C virus infection: a
case series and potential implications for disease
surveillance.  BMC Infect Dis 2001, 1:8.
41. Bari A, Akhtar S, Rahbar MH, Luby SP: Risk factors for hepatitis C
virus infection in male adults in Rawalpindi-Islamabad,
Pakistan.  Trop Med Int Health 2001, 6:732-738.
42. Crook PD, Jones ME, Hall AJ: Mortality of hepatitis B surface
antigen-positive blood donors in England and Wales.  Int J
Epidemiol 2003, 32:118-124.
43. Schlesselman JJ, Stolley PD: Case-control studies: Design, Con-
duct, Analysis.  New York: Oxford University Press; 1982. 
44. Robinson WS: Hepatitis B virus and Hepatitis D virus.  In Princi-
ples and Practice of Infectious Diseases Edited by: Mandell GL, Nemmett
JE, Dolin R. New York: Churchill Livingstone; 1995:1406-1439. 
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-230X/5/26/pre
pub